OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 54 filers reported holding OYSTER PT PHARMA INC in Q4 2022. The put-call ratio across all filers is 4.81 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $441,226 | +124.0% | 39,501 | +12.7% | 0.00% | – |
Q3 2022 | $197,000 | +44.9% | 35,057 | +11.7% | 0.00% | – |
Q2 2022 | $136,000 | -88.8% | 31,393 | -70.0% | 0.00% | – |
Q1 2022 | $1,218,000 | -39.2% | 104,673 | -4.6% | 0.00% | – |
Q4 2021 | $2,003,000 | +52.1% | 109,720 | -1.3% | 0.00% | – |
Q3 2021 | $1,317,000 | -35.3% | 111,139 | -6.2% | 0.00% | – |
Q2 2021 | $2,037,000 | +21.9% | 118,505 | +29.7% | 0.00% | – |
Q1 2021 | $1,671,000 | -13.0% | 91,392 | -10.5% | 0.00% | – |
Q4 2020 | $1,921,000 | -8.5% | 102,075 | +2.6% | 0.00% | – |
Q3 2020 | $2,100,000 | -21.8% | 99,492 | +7.0% | 0.00% | -100.0% |
Q2 2020 | $2,684,000 | +11.0% | 92,961 | +34.6% | 0.00% | 0.0% |
Q1 2020 | $2,418,000 | +50.8% | 69,089 | +5.4% | 0.00% | – |
Q4 2019 | $1,603,000 | – | 65,554 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 2,768,586 | $50,554,000 | 15.36% |
KPCB XIV Associates, LLC | 367,987 | $6,719,000 | 4.17% |
NEA Management Company, LLC | 5,925,287 | $108,196,000 | 2.19% |
Paradigm Biocapital Advisors LP | 304,238 | $5,555,000 | 1.59% |
Sio Capital Management, LLC | 181,857 | $3,321,000 | 1.00% |
COWEN AND COMPANY, LLC | 509,794 | $9,309,000 | 0.84% |
RTW INVESTMENTS, LP | 2,058,504 | $37,588,000 | 0.55% |
ACT CAPITAL MANAGEMENT, LLC | 13,500 | $247,000 | 0.18% |
COOPER CREEK PARTNERS MANAGEMENT LLC | 79,510 | $1,452,000 | 0.17% |
Point72 Asset Management, L.P. | 2,101,441 | $38,372,000 | 0.15% |